开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2162895, encodeId=d9e02162895f6, content=偏重的研究方向：内镜 经验分享：投稿了半个月了，一直是alt reviewer invited，这是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=zhangyuanyuan4968, createdTime=Sun Oct 15 15:37:36 CST 2023, time=2023-10-15, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神，alt reviewer invited是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向：RCT 经验分享：投稿20天，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒，白白浪费3个多月，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2168020, encodeId=051d2168020ca, content=先是with editor不到一个月返回是大修，然后又等了接近1个月返回是小修后接受（仅仅是解释一下麻醉的方法），r然后Review(s) Pending了一个月还没动静，啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5268141412, createdName=ms9000000433982885, createdTime=Sat Nov 11 19:49:00 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：美国消化内镜协会会刊，是牛刊，八年制童鞋一枚，非常荣幸，中了一篇！2013-11-30投稿，2014-03-15接收。临床横断面研究。中间经历2次大修，1次小修。过程很艰辛，很辛苦~问题很专业，很刁钻，但编辑很好，非常友好~ 建议和态度很好！认真修改，态度要好，问题回答好，会有机会。之前我投了2篇，都被审稿后拒掉，没给回答问题的机会，灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了，以前因为单位还算点小分，现在已经完全不算了，不过因为阅读习惯，每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些，主要因为发表的article数量和review数量都明显更多，内容也更庞杂，所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了，没有的话就是没送审。文章如果送审了的话初审很快，一般一个月以内肯定有初步决定，但是到最后接收一般要三四个月。内容方面强调创新，前瞻性的新技术哪怕样本量比较小，实验设计比较简单也存在发的可能，相反回顾性的单中心一般很困难，国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内镜;临床 经验分享：之前投了一篇，一周就给结果了，推荐投子刊，又投一篇，快1月了，还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向：原创;内镜;临床 经验分享：前天投稿临床回顾性队列研究，昨天with editor，全程直播过程，求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向：内镜 经验分享：现在很慢啊？with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省)]

2023-10-15 zhangyuanyuan4968 来自雪兰莪

偏重的研究方向：内镜
经验分享：投稿了半个月了，一直是alt reviewer invited，这是啥意思

96 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2162895, encodeId=d9e02162895f6, content=偏重的研究方向：内镜 经验分享：投稿了半个月了，一直是alt reviewer invited，这是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=zhangyuanyuan4968, createdTime=Sun Oct 15 15:37:36 CST 2023, time=2023-10-15, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神，alt reviewer invited是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向：RCT 经验分享：投稿20天，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒，白白浪费3个多月，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2168020, encodeId=051d2168020ca, content=先是with editor不到一个月返回是大修，然后又等了接近1个月返回是小修后接受（仅仅是解释一下麻醉的方法），r然后Review(s) Pending了一个月还没动静，啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5268141412, createdName=ms9000000433982885, createdTime=Sat Nov 11 19:49:00 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：美国消化内镜协会会刊，是牛刊，八年制童鞋一枚，非常荣幸，中了一篇！2013-11-30投稿，2014-03-15接收。临床横断面研究。中间经历2次大修，1次小修。过程很艰辛，很辛苦~问题很专业，很刁钻，但编辑很好，非常友好~ 建议和态度很好！认真修改，态度要好，问题回答好，会有机会。之前我投了2篇，都被审稿后拒掉，没给回答问题的机会，灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了，以前因为单位还算点小分，现在已经完全不算了，不过因为阅读习惯，每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些，主要因为发表的article数量和review数量都明显更多，内容也更庞杂，所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了，没有的话就是没送审。文章如果送审了的话初审很快，一般一个月以内肯定有初步决定，但是到最后接收一般要三四个月。内容方面强调创新，前瞻性的新技术哪怕样本量比较小，实验设计比较简单也存在发的可能，相反回顾性的单中心一般很困难，国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内镜;临床 经验分享：之前投了一篇，一周就给结果了，推荐投子刊，又投一篇，快1月了，还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向：原创;内镜;临床 经验分享：前天投稿临床回顾性队列研究，昨天with editor，全程直播过程，求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向：内镜 经验分享：现在很慢啊？with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省)]

2022-08-09 sky110319

请教各位大神，alt reviewer invited是什么意思？

126 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2162895, encodeId=d9e02162895f6, content=偏重的研究方向：内镜 经验分享：投稿了半个月了，一直是alt reviewer invited，这是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=zhangyuanyuan4968, createdTime=Sun Oct 15 15:37:36 CST 2023, time=2023-10-15, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神，alt reviewer invited是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向：RCT 经验分享：投稿20天，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒，白白浪费3个多月，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2168020, encodeId=051d2168020ca, content=先是with editor不到一个月返回是大修，然后又等了接近1个月返回是小修后接受（仅仅是解释一下麻醉的方法），r然后Review(s) Pending了一个月还没动静，啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5268141412, createdName=ms9000000433982885, createdTime=Sat Nov 11 19:49:00 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：美国消化内镜协会会刊，是牛刊，八年制童鞋一枚，非常荣幸，中了一篇！2013-11-30投稿，2014-03-15接收。临床横断面研究。中间经历2次大修，1次小修。过程很艰辛，很辛苦~问题很专业，很刁钻，但编辑很好，非常友好~ 建议和态度很好！认真修改，态度要好，问题回答好，会有机会。之前我投了2篇，都被审稿后拒掉，没给回答问题的机会，灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了，以前因为单位还算点小分，现在已经完全不算了，不过因为阅读习惯，每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些，主要因为发表的article数量和review数量都明显更多，内容也更庞杂，所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了，没有的话就是没送审。文章如果送审了的话初审很快，一般一个月以内肯定有初步决定，但是到最后接收一般要三四个月。内容方面强调创新，前瞻性的新技术哪怕样本量比较小，实验设计比较简单也存在发的可能，相反回顾性的单中心一般很困难，国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内镜;临床 经验分享：之前投了一篇，一周就给结果了，推荐投子刊，又投一篇，快1月了，还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向：原创;内镜;临床 经验分享：前天投稿临床回顾性队列研究，昨天with editor，全程直播过程，求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向：内镜 经验分享：现在很慢啊？with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省)]

2024-06-04 Latte2024 来自雪兰莪

偏重的研究方向：RCT
经验分享：投稿20天，还是with editor

56 0

[GetPortalCommentsPageByObjectIdResponse(id=2162895, encodeId=d9e02162895f6, content=偏重的研究方向：内镜 经验分享：投稿了半个月了，一直是alt reviewer invited，这是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=zhangyuanyuan4968, createdTime=Sun Oct 15 15:37:36 CST 2023, time=2023-10-15, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神，alt reviewer invited是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向：RCT 经验分享：投稿20天，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒，白白浪费3个多月，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2168020, encodeId=051d2168020ca, content=先是with editor不到一个月返回是大修，然后又等了接近1个月返回是小修后接受（仅仅是解释一下麻醉的方法），r然后Review(s) Pending了一个月还没动静，啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5268141412, createdName=ms9000000433982885, createdTime=Sat Nov 11 19:49:00 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：美国消化内镜协会会刊，是牛刊，八年制童鞋一枚，非常荣幸，中了一篇！2013-11-30投稿，2014-03-15接收。临床横断面研究。中间经历2次大修，1次小修。过程很艰辛，很辛苦~问题很专业，很刁钻，但编辑很好，非常友好~ 建议和态度很好！认真修改，态度要好，问题回答好，会有机会。之前我投了2篇，都被审稿后拒掉，没给回答问题的机会，灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了，以前因为单位还算点小分，现在已经完全不算了，不过因为阅读习惯，每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些，主要因为发表的article数量和review数量都明显更多，内容也更庞杂，所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了，没有的话就是没送审。文章如果送审了的话初审很快，一般一个月以内肯定有初步决定，但是到最后接收一般要三四个月。内容方面强调创新，前瞻性的新技术哪怕样本量比较小，实验设计比较简单也存在发的可能，相反回顾性的单中心一般很困难，国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内镜;临床 经验分享：之前投了一篇，一周就给结果了，推荐投子刊，又投一篇，快1月了，还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向：原创;内镜;临床 经验分享：前天投稿临床回顾性队列研究，昨天with editor，全程直播过程，求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向：内镜 经验分享：现在很慢啊？with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省)]

2023-11-18 ms6000001032864519 来自山东省

返修后被拒，白白浪费3个多月，哎

118 0

[GetPortalCommentsPageByObjectIdResponse(id=2162895, encodeId=d9e02162895f6, content=偏重的研究方向：内镜 经验分享：投稿了半个月了，一直是alt reviewer invited，这是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=zhangyuanyuan4968, createdTime=Sun Oct 15 15:37:36 CST 2023, time=2023-10-15, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神，alt reviewer invited是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向：RCT 经验分享：投稿20天，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒，白白浪费3个多月，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2168020, encodeId=051d2168020ca, content=先是with editor不到一个月返回是大修，然后又等了接近1个月返回是小修后接受（仅仅是解释一下麻醉的方法），r然后Review(s) Pending了一个月还没动静，啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5268141412, createdName=ms9000000433982885, createdTime=Sat Nov 11 19:49:00 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：美国消化内镜协会会刊，是牛刊，八年制童鞋一枚，非常荣幸，中了一篇！2013-11-30投稿，2014-03-15接收。临床横断面研究。中间经历2次大修，1次小修。过程很艰辛，很辛苦~问题很专业，很刁钻，但编辑很好，非常友好~ 建议和态度很好！认真修改，态度要好，问题回答好，会有机会。之前我投了2篇，都被审稿后拒掉，没给回答问题的机会，灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了，以前因为单位还算点小分，现在已经完全不算了，不过因为阅读习惯，每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些，主要因为发表的article数量和review数量都明显更多，内容也更庞杂，所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了，没有的话就是没送审。文章如果送审了的话初审很快，一般一个月以内肯定有初步决定，但是到最后接收一般要三四个月。内容方面强调创新，前瞻性的新技术哪怕样本量比较小，实验设计比较简单也存在发的可能，相反回顾性的单中心一般很困难，国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内镜;临床 经验分享：之前投了一篇，一周就给结果了，推荐投子刊，又投一篇，快1月了，还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向：原创;内镜;临床 经验分享：前天投稿临床回顾性队列研究，昨天with editor，全程直播过程，求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向：内镜 经验分享：现在很慢啊？with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省)]

2023-11-11 ms9000000433982885 来自北京

先是with editor不到一个月返回是大修，然后又等了接近1个月返回是小修后接受（仅仅是解释一下麻醉的方法），r然后Review(s) Pending了一个月还没动静，啥意思？

86 0

[GetPortalCommentsPageByObjectIdResponse(id=2162895, encodeId=d9e02162895f6, content=偏重的研究方向：内镜 经验分享：投稿了半个月了，一直是alt reviewer invited，这是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=zhangyuanyuan4968, createdTime=Sun Oct 15 15:37:36 CST 2023, time=2023-10-15, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神，alt reviewer invited是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向：RCT 经验分享：投稿20天，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒，白白浪费3个多月，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2168020, encodeId=051d2168020ca, content=先是with editor不到一个月返回是大修，然后又等了接近1个月返回是小修后接受（仅仅是解释一下麻醉的方法），r然后Review(s) Pending了一个月还没动静，啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5268141412, createdName=ms9000000433982885, createdTime=Sat Nov 11 19:49:00 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：美国消化内镜协会会刊，是牛刊，八年制童鞋一枚，非常荣幸，中了一篇！2013-11-30投稿，2014-03-15接收。临床横断面研究。中间经历2次大修，1次小修。过程很艰辛，很辛苦~问题很专业，很刁钻，但编辑很好，非常友好~ 建议和态度很好！认真修改，态度要好，问题回答好，会有机会。之前我投了2篇，都被审稿后拒掉，没给回答问题的机会，灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了，以前因为单位还算点小分，现在已经完全不算了，不过因为阅读习惯，每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些，主要因为发表的article数量和review数量都明显更多，内容也更庞杂，所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了，没有的话就是没送审。文章如果送审了的话初审很快，一般一个月以内肯定有初步决定，但是到最后接收一般要三四个月。内容方面强调创新，前瞻性的新技术哪怕样本量比较小，实验设计比较简单也存在发的可能，相反回顾性的单中心一般很困难，国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内镜;临床 经验分享：之前投了一篇，一周就给结果了，推荐投子刊，又投一篇，快1月了，还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向：原创;内镜;临床 经验分享：前天投稿临床回顾性队列研究，昨天with editor，全程直播过程，求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向：内镜 经验分享：现在很慢啊？with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省)]

2014-03-15 qwg19912844

审稿速度:6.0 | 投稿命中率:25.0
经验分享：美国消化内镜协会会刊，是牛刊，八年制童鞋一枚，非常荣幸，中了一篇！2013-11-30投稿，2014-03-15接收。临床横断面研究。中间经历2次大修，1次小修。过程很艰辛，很辛苦~问题很专业，很刁钻，但编辑很好，非常友好~ 建议和态度很好！认真修改，态度要好，问题回答好，会有机会。之前我投了2篇，都被审稿后拒掉，没给回答问题的机会，灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~

486 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2162895, encodeId=d9e02162895f6, content=偏重的研究方向：内镜 经验分享：投稿了半个月了，一直是alt reviewer invited，这是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=zhangyuanyuan4968, createdTime=Sun Oct 15 15:37:36 CST 2023, time=2023-10-15, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神，alt reviewer invited是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向：RCT 经验分享：投稿20天，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒，白白浪费3个多月，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2168020, encodeId=051d2168020ca, content=先是with editor不到一个月返回是大修，然后又等了接近1个月返回是小修后接受（仅仅是解释一下麻醉的方法），r然后Review(s) Pending了一个月还没动静，啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5268141412, createdName=ms9000000433982885, createdTime=Sat Nov 11 19:49:00 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：美国消化内镜协会会刊，是牛刊，八年制童鞋一枚，非常荣幸，中了一篇！2013-11-30投稿，2014-03-15接收。临床横断面研究。中间经历2次大修，1次小修。过程很艰辛，很辛苦~问题很专业，很刁钻，但编辑很好，非常友好~ 建议和态度很好！认真修改，态度要好，问题回答好，会有机会。之前我投了2篇，都被审稿后拒掉，没给回答问题的机会，灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了，以前因为单位还算点小分，现在已经完全不算了，不过因为阅读习惯，每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些，主要因为发表的article数量和review数量都明显更多，内容也更庞杂，所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了，没有的话就是没送审。文章如果送审了的话初审很快，一般一个月以内肯定有初步决定，但是到最后接收一般要三四个月。内容方面强调创新，前瞻性的新技术哪怕样本量比较小，实验设计比较简单也存在发的可能，相反回顾性的单中心一般很困难，国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内镜;临床 经验分享：之前投了一篇，一周就给结果了，推荐投子刊，又投一篇，快1月了，还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向：原创;内镜;临床 经验分享：前天投稿临床回顾性队列研究，昨天with editor，全程直播过程，求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向：内镜 经验分享：现在很慢啊？with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省)]

2023-10-14 doctor10 来自四川省

在GIE发了10篇letter了，以前因为单位还算点小分，现在已经完全不算了，不过因为阅读习惯，每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些，主要因为发表的article数量和review数量都明显更多，内容也更庞杂，所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了，没有的话就是没送审。文章如果送审了的话初审很快，一般一个月以内肯定有初步决定，但是到最后接收一般要三四个月。内容方面强调创新，前瞻性的新技术哪怕样本量比较小，实验设计比较简单也存在发的可能，相反回顾性的单中心一般很困难，国内基本也就复旦中山等几个医院有可能

163 0

[GetPortalCommentsPageByObjectIdResponse(id=2162895, encodeId=d9e02162895f6, content=偏重的研究方向：内镜 经验分享：投稿了半个月了，一直是alt reviewer invited，这是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=zhangyuanyuan4968, createdTime=Sun Oct 15 15:37:36 CST 2023, time=2023-10-15, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神，alt reviewer invited是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向：RCT 经验分享：投稿20天，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒，白白浪费3个多月，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2168020, encodeId=051d2168020ca, content=先是with editor不到一个月返回是大修，然后又等了接近1个月返回是小修后接受（仅仅是解释一下麻醉的方法），r然后Review(s) Pending了一个月还没动静，啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5268141412, createdName=ms9000000433982885, createdTime=Sat Nov 11 19:49:00 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：美国消化内镜协会会刊，是牛刊，八年制童鞋一枚，非常荣幸，中了一篇！2013-11-30投稿，2014-03-15接收。临床横断面研究。中间经历2次大修，1次小修。过程很艰辛，很辛苦~问题很专业，很刁钻，但编辑很好，非常友好~ 建议和态度很好！认真修改，态度要好，问题回答好，会有机会。之前我投了2篇，都被审稿后拒掉，没给回答问题的机会，灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了，以前因为单位还算点小分，现在已经完全不算了，不过因为阅读习惯，每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些，主要因为发表的article数量和review数量都明显更多，内容也更庞杂，所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了，没有的话就是没送审。文章如果送审了的话初审很快，一般一个月以内肯定有初步决定，但是到最后接收一般要三四个月。内容方面强调创新，前瞻性的新技术哪怕样本量比较小，实验设计比较简单也存在发的可能，相反回顾性的单中心一般很困难，国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内镜;临床 经验分享：之前投了一篇，一周就给结果了，推荐投子刊，又投一篇，快1月了，还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向：原创;内镜;临床 经验分享：前天投稿临床回顾性队列研究，昨天with editor，全程直播过程，求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向：内镜 经验分享：现在很慢啊？with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省)]

2023-04-09 猫游记来自四川省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：内镜;临床
经验分享：之前投了一篇，一周就给结果了，推荐投子刊，又投一篇，快1月了，还在with editor,搞不懂

114 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2162895, encodeId=d9e02162895f6, content=偏重的研究方向：内镜 经验分享：投稿了半个月了，一直是alt reviewer invited，这是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=zhangyuanyuan4968, createdTime=Sun Oct 15 15:37:36 CST 2023, time=2023-10-15, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神，alt reviewer invited是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向：RCT 经验分享：投稿20天，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒，白白浪费3个多月，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2168020, encodeId=051d2168020ca, content=先是with editor不到一个月返回是大修，然后又等了接近1个月返回是小修后接受（仅仅是解释一下麻醉的方法），r然后Review(s) Pending了一个月还没动静，啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5268141412, createdName=ms9000000433982885, createdTime=Sat Nov 11 19:49:00 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：美国消化内镜协会会刊，是牛刊，八年制童鞋一枚，非常荣幸，中了一篇！2013-11-30投稿，2014-03-15接收。临床横断面研究。中间经历2次大修，1次小修。过程很艰辛，很辛苦~问题很专业，很刁钻，但编辑很好，非常友好~ 建议和态度很好！认真修改，态度要好，问题回答好，会有机会。之前我投了2篇，都被审稿后拒掉，没给回答问题的机会，灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了，以前因为单位还算点小分，现在已经完全不算了，不过因为阅读习惯，每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些，主要因为发表的article数量和review数量都明显更多，内容也更庞杂，所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了，没有的话就是没送审。文章如果送审了的话初审很快，一般一个月以内肯定有初步决定，但是到最后接收一般要三四个月。内容方面强调创新，前瞻性的新技术哪怕样本量比较小，实验设计比较简单也存在发的可能，相反回顾性的单中心一般很困难，国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内镜;临床 经验分享：之前投了一篇，一周就给结果了，推荐投子刊，又投一篇，快1月了，还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向：原创;内镜;临床 经验分享：前天投稿临床回顾性队列研究，昨天with editor，全程直播过程，求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向：内镜 经验分享：现在很慢啊？with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省)]

2021-09-14 120a6ac7m01(暂无昵称)

偏重的研究方向：原创;内镜;临床
经验分享：前天投稿临床回顾性队列研究，昨天with editor，全程直播过程，求好运吧!

140 34

展开34条回复

[GetPortalCommentsPageByObjectIdResponse(id=2162895, encodeId=d9e02162895f6, content=偏重的研究方向：内镜 经验分享：投稿了半个月了，一直是alt reviewer invited，这是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=zhangyuanyuan4968, createdTime=Sun Oct 15 15:37:36 CST 2023, time=2023-10-15, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神，alt reviewer invited是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向：RCT 经验分享：投稿20天，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒，白白浪费3个多月，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2168020, encodeId=051d2168020ca, content=先是with editor不到一个月返回是大修，然后又等了接近1个月返回是小修后接受（仅仅是解释一下麻醉的方法），r然后Review(s) Pending了一个月还没动静，啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5268141412, createdName=ms9000000433982885, createdTime=Sat Nov 11 19:49:00 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：美国消化内镜协会会刊，是牛刊，八年制童鞋一枚，非常荣幸，中了一篇！2013-11-30投稿，2014-03-15接收。临床横断面研究。中间经历2次大修，1次小修。过程很艰辛，很辛苦~问题很专业，很刁钻，但编辑很好，非常友好~ 建议和态度很好！认真修改，态度要好，问题回答好，会有机会。之前我投了2篇，都被审稿后拒掉，没给回答问题的机会，灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了，以前因为单位还算点小分，现在已经完全不算了，不过因为阅读习惯，每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些，主要因为发表的article数量和review数量都明显更多，内容也更庞杂，所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了，没有的话就是没送审。文章如果送审了的话初审很快，一般一个月以内肯定有初步决定，但是到最后接收一般要三四个月。内容方面强调创新，前瞻性的新技术哪怕样本量比较小，实验设计比较简单也存在发的可能，相反回顾性的单中心一般很困难，国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内镜;临床 经验分享：之前投了一篇，一周就给结果了，推荐投子刊，又投一篇，快1月了，还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向：原创;内镜;临床 经验分享：前天投稿临床回顾性队列研究，昨天with editor，全程直播过程，求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向：内镜 经验分享：现在很慢啊？with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省)]

2023-07-10 fzdndx 来自江苏省

偏重的研究方向：内镜
经验分享：现在很慢啊？with editor 20天了

96 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务